Lucero
Desconocido
LUCERO-BIO: LUCERO BIO: Smart Optofluidic Isolation of Spheroids for Early-Stage Drug Discovery
Lucero AB
tramitó un
HORIZON EUROPE:
HORIZON-EIC-2021-TRANSITIONOPEN-01
Personalised medicine has become a key focus for the pharmaceutical industry as it can address global health challenges, such as
strong vari...
2022-10-26 - 2025-12-31 | Financiado
2022-10-26 - 2025-12-31 | Financiado
* No se disponen de datos de la empresa actual.